English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Tabitha Fleming | Jun 2, 2017

European Commission approves dinutuximab beta for treating high-risk neuroblastoma

Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe

Tabitha Fleming | May 26, 2017

National Institute on Alcohol Abuse and Alcoholism releases 5-year action plan

Tabitha Fleming | May 26, 2017

American Academy of Family Physicians supports guidelines for osteoporosis treatment

Tabitha Fleming | May 25, 2017

Nautilus Medical working to increase patient access to radiology reports

Tabitha Fleming | May 14, 2017

Lupus Foundation of America promotes awareness of disease

Tabitha Fleming | Mar 10, 2017

Genetic engineering could make jeans cheaper to produce

Tabitha Fleming | Mar 1, 2017

Utah, Lousiana issue standing order for opioid overdose drug

Trending

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’

  • 1
  • 2
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily